Rare diseases and special populations drive change in the models and concepts underlying therapeutic development for even the most common diseases. DIA elevates these unique perspectives and contributions throughout the global healthcare ecosystem via our communities, content, and meetings.
Accelerating Pediatric Drug Development: A 2022 Special Issue of Therapeutic Innovation & Regulatory Science
This pediatric special issue of TIRS propels us into the next phase of pediatric drug development focused on innovative trial designs, issues related to rare diseases and pregnant individuals, advances in pediatric formulation development, development of digital technologies in pediatric trials, an update on pediatric global networks, and a discussion of stakeholder engagement with a focus on health equity and the voices of the children and their families.
Submit an Abstract
Submit an abstract for an existing or future event on any topic that advances the pharmaceutical, biotechnology, medical device, and related fields.
Content Highlights
Learn More
eLearning Program
The Drug Safety eLearning Program provides the knowledge you need, from regulations and requirements through pre-market review and post-market monitoring.
Patient Engagement Certficate Program
There is an ever-expanding area of collaboration that is occurring among patients, patient organizations, industry, regulators, and governmental organizations to ensure that new drugs developed represent value to the patients they aim to treat, that patient access to innovations is accelerated, and that patient experience and outcomes are optimal.